Sign in / Join Now
ETFs & Funds
Biotech co $
up 70% since 11/15 IPO on fairly low volume. Only one major drug in late-stage development. I'd be wary of this one.
Add a reply...
Latest StockTalks »
people get RLYP breaking news and analysis by email alert.
Get email alerts on RLYP »
Get latest price
From other sites
Relypsa Announces Data On The Treatment And Impact Of Hyperkalemia To Be Presented At ASN Kidney Week 2016
at TheStreet (Nov 3, 2016)
Relypsa Announces Phase 4 Study Shows Veltassa® Demonstrated Similar Efficacy And Safety Whether Given With Or Without Food In Patients With Hyperkalemia
at TheStreet (Aug 30, 2016)
Relypsa (RLYP) Stock Downgraded to 'Hold' at Stifel
at TheStreet (Aug 22, 2016)
Short Interest Declines 42.5% For RLYP
at TheStreet (Aug 10, 2016)
Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
at TheStreet (Jul 29, 2016)